Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention
Paul Dietze, Kate Cantwell
Abstract
Open-access reader
Paul Dietze, Kate Cantwell
Abstract
Open-access reader
Commentary to: Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Commentary to: Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
Key concepts: Opioid overdose, (+)-Naloxone, Opioid, Medicine, Opioid epidemic, Opioid-Related Disorders, Nasal administration, Drug overdose